semaglutide lizard venom EP17: From to a $50 billion weight loss industry? 🦎 The fascinating origin story of today's most talked-about medications traces back to a peculiar discovery about America's only venomous lizard We wouldn't have Ozempic without

And thats why GLP-1s are very confusing, but if you want a patient to be successful on them, you want to make sure youve got the lifestyle, you got the right expectations, you know what the entry point is, what the duration is, and more importantly, what happens when they hit a weight and quote unquote, what is the endpoint of GLP-1s

Pandey P, et al

GLP-1 and GLP-1/GIP medications are approved to treat type 2 diabetes mellitus, obesity, and metabolic dysfunction-associated steatohepatitis (MASH) with added benefits in patients with cardiovascular disease and renal disease [4, 5]

Results and Discussion Among the study participants, the majority were White (62%) and female (51%), while the South was the most commonly represented region (42%), with a mean Charlson Comorbidity Index (CCI) of 1.12

you must be willing to see whats actually going on